CJC-1295 DAC is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
CJC-1295 DAC is one of the most discussed peptides in the research community, with reports focusing on its effects on sustained GH elevation, elevated IGF-1 levels, enhanced protein synthesis, improved body composition, increased muscle mass. Single dose increases plasma GH 2-10 fold for 6+ days and IGF-1 0.5-3 fold for 9-11 days in humans. Multiple clinical trials demonstrated sustained dose-dependent GH/IGF-1 elevation. Reached Phase II before discontinuation.
What Do Researchers Report About CJC-1295 DAC?
CJC-1295 DAC (CJC-1295 with Drug Affinity Complex) is one of the most discussed GHRH analog with extended half-life compounds in the peptide research community. Reports span effects on sustained GH elevation, elevated IGF-1 levels, enhanced protein synthesis, improved body composition, increased muscle mass.
Single dose increases plasma GH 2-10 fold for 6+ days and IGF-1 0.5-3 fold for 9-11 days in humans. Multiple clinical trials demonstrated sustained dose-dependent GH/IGF-1 elevation. Reached Phase II before discontinuation.
What Are the Most Common Positive Reports?
Researchers frequently cite CJC-1295 DAC's effects on sustained GH elevation, elevated IGF-1 levels, enhanced protein synthesis, improved body composition, increased muscle mass as the primary benefits observed during standard cycles of 12-16 weeks.
The only GHRH analog with extended half-life allowing once-weekly dosing — but this convenience comes at the cost of sustained supraphysiological GH levels that bypass natural feedback, which is why most researchers prefer the no-DAC version. This distinctive profile is a key reason CJC-1295 DAC maintains its popularity despite the growing number of alternatives.
What Are the Common Criticisms?
The most common complaints about CJC-1295 DAC: Water retention, joint aches, fluid retention, mild headache. Sustained GH elevation may cause more pronounced side effects than pulsatile release versions. One subject death in Phase II trial was attributed to unrelated coronary artery disease.
Cost and sourcing quality are also frequent concerns — results vary significantly between vendors, which is why COA testing is essential.
How Does CJC-1295 DAC Compare to Alternatives?
As a GHRH analog with extended half-life, CJC-1295 DAC competes with several similar compounds. The only GHRH analog with extended half-life allowing once-weekly dosing — but this convenience comes at the cost of sustained supraphysiological GH levels that bypass natural feedback, which is why most researchers prefer the no-DAC version.
Synergizes with GHRP-6 or GHRP-2 for amplified GH pulse amplitude. The sustained release makes it less ideal for stacking than CJC-1295 no DAC, which preserves natural pulsatility.
Bottom Line: Is CJC-1295 DAC Worth It?
Based on the available research and community reports, CJC-1295 DAC is considered promising for sustained GH elevation, elevated IGF-1 levels, enhanced protein synthesis, improved body composition, increased muscle mass. The key factors for success: consistent dosing (1-2 mg per injection once or twice weekly), quality sourcing, and realistic expectations over 12-16 weeks cycles.
Complete Guide
CJC-1295 DAC : Benefits, Dosage, Side Effects & Research
Related Reading
- CJC-1295 DAC Dosage Guide
- CJC-1295 DAC Benefits
- CJC-1295 DAC Side Effects
- CJC-1295 DAC Stacking Guide
- CJC-1295 DAC Cycle Guide
- CJC-1295 DAC Research
Calculate Your CJC-1295 DAC Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for CJC-1295 DAC.
Open Calculator →Research-Grade Sourcing
If you're going to research CJC-1295 DAC, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is CJC-1295 DAC?
CJC-1295 DAC (CJC-1295 with Drug Affinity Complex) is a GHRH analog with extended half-life. Synthetic GHRH analog with four amino acid substitutions conjugated to a drug affinity complex that binds endogenous albumin. It is researched for sustained GH elevation, elevated IGF-1 levels, enhanced protein synthesis, improved body composition, increased muscle mass.
What is the recommended CJC-1295 DAC dosage?
Common dosages: 1-2 mg per injection administered once or twice weekly via subcutaneous injection. Cycle length: 12-16 weeks. Half-life: 6-8 days. Use our peptide calculator for exact reconstitution math.
What are the side effects of CJC-1295 DAC?
Water retention, joint aches, fluid retention, mild headache. Sustained GH elevation may cause more pronounced side effects than pulsatile release versions. One subject death in Phase II trial was attributed to unrelated coronary artery disease.
Is CJC-1295 DAC safe?
CJC-1295 DAC has shown a preliminary safety profile in research. Not FDA-approved. Development discontinued post-Phase II. WADA banned. Available as research peptide. All research should follow appropriate safety protocols.